Juan Valor-Vicente

Madrid, MD 28040, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Serum Short-Chain Fatty Acids in Colorectal Cancer: Diagnostic Performance and Decoupling from Gut Producer Abundance.

Serum Short-Chain Fatty Acids in Colorectal Cancer: Diagnostic Performance and Decoupling from Gut Producer Abundance.

Journal: Cells

Published: May 22, 2026

Microbiota biomarkers as predictors on immunotherapy response in patients with advanced non-small cell lung cancer.

Microbiota biomarkers as predictors on immunotherapy response in patients with advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 14, 2026

Identification of clinically relevant profiles in colorectal cancer through integrated analysis of bacterial DNA and metabolome in serum.

Identification of clinically relevant profiles in colorectal cancer through integrated analysis of bacterial DNA and metabolome in serum.

Journal: Frontiers in immunology

Published: January 17, 2025

Fecal Microbiota Strongly Correlates with Tissue Microbiota Composition in Colorectal Cancer but Not in Non-Small Cell Lung Cancer.

Fecal Microbiota Strongly Correlates with Tissue Microbiota Composition in Colorectal Cancer but Not in Non-Small Cell Lung Cancer.

Journal: International journal of molecular sciences

Published: December 12, 2024

Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers.

Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers.

Journal: Biomedicines

Published: January 30, 2024

Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.

Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.

Journal: Biomedicines

Published: November 21, 2023

Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study.

Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study.

Journal: Pharmacological reports : PR

Published: April 08, 2023

Possible heart failure caused by osimertinib in a lung cancer patient.

Possible heart failure caused by osimertinib in a lung cancer patient.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: December 08, 2022

Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients.

Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: January 17, 2022

Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice.

Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice.

Journal: Expert opinion on drug metabolism & toxicology

Published: January 10, 2022

PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort.

PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 30, 2021

COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.

COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.

Journal: International journal of antimicrobial agents

Published: July 16, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026